KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Minority Interest (2016 - 2025)

Historic Minority Interest for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $295.0 million.

  • Pfizer's Minority Interest rose 845.59% to $295.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $295.0 million, marking a year-over-year increase of 845.59%. This contributed to the annual value of $294.0 million for FY2024, which is 729.93% up from last year.
  • Latest data reveals that Pfizer reported Minority Interest of $295.0 million as of Q3 2025, which was up 845.59% from $317.0 million recorded in Q2 2025.
  • In the past 5 years, Pfizer's Minority Interest registered a high of $317.0 million during Q2 2025, and its lowest value of $227.0 million during Q4 2022.
  • In the last 5 years, Pfizer's Minority Interest had a median value of $273.0 million in 2021 and averaged $272.4 million.
  • Within the past 5 years, the most significant YoY rise in Pfizer's Minority Interest was 1973.68% (2021), while the steepest drop was 2147.44% (2021).
  • Pfizer's Minority Interest (Quarter) stood at $262.0 million in 2021, then fell by 2.29% to $256.0 million in 2022, then increased by 7.03% to $274.0 million in 2023, then rose by 7.3% to $294.0 million in 2024, then increased by 0.34% to $295.0 million in 2025.
  • Its Minority Interest stands at $295.0 million for Q3 2025, versus $317.0 million for Q2 2025 and $299.0 million for Q1 2025.